Paroxetine and congenital malformations: Meta-Analysis and consideration of potential confounding factors
- 1 May 2007
- journal article
- research article
- Published by Elsevier in Clinical Therapeutics
- Vol. 29 (5) , 918-926
- https://doi.org/10.1016/j.clinthera.2007.05.003
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Antidepressant drugs during pregnancy and infant congenital heart defectReproductive Toxicology, 2006
- Remission of Generalized Anxiety DisorderThe Journal of Clinical Psychiatry, 2006
- Newer antidepressants in pregnancy and rates of major malformations: a meta-analysis of prospective comparative studiesPharmacoepidemiology and Drug Safety, 2005
- Risks Associated With Selective Serotonin Reuptake Inhibitors in PregnancyObstetrics & Gynecology, 2005
- The Use of Selective Serotonin Reuptake Inhibitors During Pregnancy and Breast-feedingJournal of Clinical Psychopharmacology, 2005
- Maternal Depressive Symptoms and Children's Receipt of Health Care in the First 3 Years of LifePediatrics, 2005
- Outcomes of Prenatal Antidepressant ExposureAmerican Journal of Psychiatry, 2002
- The use of prescription claims databases in pharmacoepidemiological research: The accuracy and comprehensiveness of the prescription claims database in QuébecPublished by Elsevier ,1995
- The Impact of Parental Trait Anxiety on the Utilization of Health Care Services in Infancy: A Prospective StudyJournal of Pediatric Psychology, 1994
- A study of an urban health centre: factors influencing contact with mothers and their babiesChild: Care, Health and Development, 1981